AIRR - ANZCA Institutional Research Repository
Skip navigation

Professor Michael Paech

Publications

Results 1-8 of 8 (Search time: 0.001 seconds).

PreviewIssue DateTitleAuthor(s)
1May-2017A randomised double-blind trial of phenylephrine and metaraminol infusions for prevention of hypotension during spinal and combined-spinal epidural anaesthesia for elective caesarean section.McDonnell, NJ Paech, MJ Muchatuta, NAHillyard, S Nathan, EA
2May-2016Severe Nausea and Vomiting in the Evaluation of Nitrous Oxide in the Gas Mixture for Anesthesia II TrialMyles PS Chan MTKasza JPaech MJ Leslie K Peyton PJSessler DIHaller GBeattie WSOsborne CSneyd JRForbes A
318-Oct-2014The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial.Myles, PS Leslie, K Chan, MTV Forbes, APeyton, PJ Paech, MJ Beattie, SSessler, DIDevereaux, PJSilbert, BS Schricker, TWallace, SANZCA Trials Group for the ENIGMA-II investigators
4Aug-2011A cost-benefit analysis of the ENIGMA trialGraham, AMMyles, PS Leslie, K Chan, MTPaech, MJ Peyton, PJ El Dawlatly, AA
5Feb-2011Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial.Leslie, K Myles, PS Chan, MTV Forbes, APaech, MJ Peyton, PJ Silbert, BS Williamson, E
6Oct-2008Difficult and failed intubation in obstetric anaesthesia: an observational study of airway management and complications associated with general anaesthesia for caesarean section.McDonnell, NJ Paech, MJ Clavisi, OMScott, KLANZCA Clinical Trials Network 
7Oct-2008A prospective study of awareness and recall associated with general anaesthesia for caesarean section.Paech, MJ Scott, KLClavisi, OChua, SMcDonnell, NJ ANZCA Clinical Trials Network 
8-Implication of Major Adverse Postoperative Events and Myocardial Injury on Disability and Survival: A Planned Subanalysis of the ENIGMA-II Trial.Beattie, WSWijeysundera, DNChan, MTV Peyton, PJ Leslie, K Paech, MJ Sessler, DIWallace, SMyles, PS Galagher, WFarrington, CDitoro, ABaulch, SSidiropoulos, SBulach, RBryant, DO'Loughlin, E Mitteregger, VBolsin, SOsborne, CMcRae, RBackstrom, MCotter, RMarch, SSilbert, BSaid, SHalliwell, RCope, JFahlbusch, DCrump, DThompson, GJefferies, AReeves, MBuckley, NTidy, TSchricker, TLattermann, RIannuzzi, DCarroll, JJacka, MBryden, CBadner, NTsang, MWYCheng, BCPFong, ACMChu, LCY Koo, EGYMohd, NMing, LECampbell, DMcAllister, DWalker, SOlliff, SKennedy, REldawlatly, AAlzahrani, TChua, NSneyd, RMcMillan, HParkinson, IBrennan, ABalaji, PNightingale, JKunst, GDickinson, MSubramaniam, BBanner-Godspeed, VLiu, JKurz, AHesler, BFu, AYEgan, CFiffick, ANHutcherson MTTuran, ANaylor, AObal, DCooke, EANZCA Clinical Trials Network for the ENIGMA-II Investigators. Abstract